SAbR For Oligo-Progressive Renal Cell Cancer.
Clinical trial NCT03696277 · COMPLETED
Trial details
- NCT number
- NCT03696277
- Sponsor
- University of Texas Southwestern Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-01
- Primary completion
- 2024-01-23
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.